The Product - Aayush Dia Shield Tablets
Aayush Wellness has introduced Aayush Dia Shield Tablets, a science-backed dietary supplement designed to manage blood sugar levels through a blend of standardized herbal extracts. The formulation includes Trigonella foenum-graecum to enhance insulin response, Momordica charantia to support blood sugar regulation, Gymnema sylvestre to reduce sugar absorption, and Cinnamon Bark Extract for improved glucose utilization. This launch marks the company's entry into the preventive wellness segment, targeting the rising prevalence of metabolic health challenges in India.
The product is developed for modern lifestyles, featuring a daily format aimed at fostering repeat-consumption behavior among health-conscious consumers and working professionals.
Commercial Opportunity in Metabolic Health
- Entry into a metabolic health market valued at ₹36,656 Crore in India
- Potential reach of over 230 million individuals currently affected by diabetes or pre-diabetes
- Strategic focus on the 30-45 age group where prevalence is rising among working professionals
- Addressing the undiagnosed market segment which accounts for nearly 50% of total cases
- Designed as a preventive and supportive solution for long-term blood sugar management
Management Perspective
India’s diabetes challenge represents both a major public health priority and a significant wellness opportunity. With Aayush Dia Shield Tablets, we are strengthening our preventive healthcare portfolio with a solution aligned to evolving consumer needs and our long-term growth strategy.
Company Profile and Financial Context
Established in 1984, Aayush Wellness Limited is an ISO 9000 and 22000 certified company specializing in integrated healthcare and preventive wellness. The company reports a trailing twelve-month revenue of ₹129.43 Crore, demonstrating significant scaling compared to its historical annual performance. With a trailing twelve-month net profit of ₹4.51 Crore and an annual ROE of 40.64%, the firm maintains a strong efficiency profile.
This expansion into metabolic health leverages the company's existing distribution strengths and aligns with its objective of leading the industry through a diverse range of science-backed products that address critical national health priorities.
